Abbott Laboratories has initiated a voluntary recall of certain lots of ready-to-feed liquid products for infants and children, including the brands Similac and Pedialyte Electrolyte Solution, due to ...

"A small percentage of bottles (less than 1%) in the recalled lots have bottle caps that may hot have sealed completely," the company said in their announcement Friday Shafiq Najib is a former ...

Buy Abbott: defensive compounder with recurring cash flow. Libre diabetes devices drive growth; 2025 guidance reaffirmed.

Gift Article 10 Remaining As a subscriber, you have 10 articles to gift each month. Gifting allows recipients to access the article for free. Abbott Laboratories has agreed to discontinue sales of its ...

Abbott Laboratories CEO Robert Ford adamantly defended the company’s premature-infant formula to investors amid an ongoing trial claiming the company concealed risks associated with the products. Ford ...

Abbott Laboratories' diabetes care segment recently added new products to its lineup. It should remain one of the company's key growth drivers over the long run. There are other good reasons to invest ...

Feb 17 (Reuters) - Abbott Laboratories (ABT.N), opens new tab said on Friday it received a civil investigative demand in January from the Federal Trade Commission related to a probe of the companies ...